Is Black Diamond Stock a Good Investment?
Black Diamond Investment Advice | BDTX |
- Examine Black Diamond's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Black Diamond's leadership team and their track record. Good management can help Black Diamond navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Black Diamond's business and its evolving consumer preferences.
- Compare Black Diamond's performance and market position to its competitors. Analyze how Black Diamond is positioned in terms of product offerings, innovation, and market share.
- Check if Black Diamond pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Black Diamond's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Black Diamond Therapeutics stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Black Diamond Therapeutics is a good investment.
Sell | Buy |
Sell
Market Performance | Very Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Excited | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Black Diamond Stock
Researching Black Diamond's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 95.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Black Diamond Therap recorded a loss per share of 1.5. The entity had not issued any dividends in recent years.
To determine if Black Diamond is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Black Diamond's research are outlined below:
| Black Diamond Therap generated a negative expected return over the last 90 days | |
| Black Diamond Therap has high historical volatility and very poor performance | |
| Black Diamond Therap has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (82.44 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Black Diamond Therapeutics currently holds about 160.89 M in cash with (66.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.43, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Black Diamond Therap has a frail financial position based on the latest SEC disclosures | |
| Over 95.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Black Diamond Therapeutics, Inc. Short Interest Update |
Black Diamond uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Black Diamond Therapeutics. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Black Diamond's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Black Diamond's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Black Diamond's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-09 | 2024-03-31 | -0.43 | -0.35 | 0.08 | 18 | ||
2021-08-12 | 2021-06-30 | -0.84 | -0.95 | -0.11 | 13 | ||
2024-03-12 | 2023-12-31 | -0.47 | -0.34 | 0.13 | 27 | ||
2021-05-07 | 2021-03-31 | -0.68 | -0.84 | -0.16 | 23 | ||
2022-03-17 | 2021-12-31 | -1.01 | -0.71 | 0.3 | 29 | ||
2020-03-24 | 2019-12-31 | -1.37 | -4.63 | -3.26 | 237 |
Black Diamond Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Black target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Black Diamond's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Strong Buy |
Most Black analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Black stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Black Diamond Therap, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationBlack Diamond Target Price Projection
Black Diamond's current and average target prices are 3.31 and 11.33, respectively. The current price of Black Diamond is the price at which Black Diamond Therapeutics is currently trading. On the other hand, Black Diamond's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Black Diamond Market Quote on 21st of October 2024
Target Price
Analyst Consensus On Black Diamond Target Price
Black Diamond Analyst Ratings
Black Diamond's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Black Diamond stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Black Diamond's financials, market performance, and future outlook by experienced professionals. Black Diamond's historical ratings below, therefore, can serve as a valuable tool for investors.Know Black Diamond's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Black Diamond is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Black Diamond Therapeutics backward and forwards among themselves. Black Diamond's institutional investor refers to the entity that pools money to purchase Black Diamond's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | T. Rowe Price Associates, Inc. | 2024-06-30 | 813.1 K | Amvescap Plc. | 2024-06-30 | 712.4 K | Kennedy Capital Management Inc | 2024-06-30 | 703.3 K | State Street Corp | 2024-06-30 | 690.4 K | Stempoint Capital Lp | 2024-06-30 | 674.2 K | Affinity Asset Advisors, Llc | 2024-06-30 | 650 K | Driehaus Capital Management Llc | 2024-06-30 | 605.9 K | Exoduspoint Capital Management, Lp | 2024-06-30 | 588.6 K | Boxer Capital Llc | 2024-06-30 | 506 K | T. Rowe Price Investment Management,inc. | 2024-06-30 | 10.7 M | Bellevue Group Ag | 2024-06-30 | 8.5 M |
Black Diamond's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 187.03 M.Market Cap |
|
Black Diamond's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.52) | (0.55) | |
| Return On Capital Employed | (0.62) | (0.65) | |
| Return On Assets | (0.52) | (0.55) | |
| Return On Equity | (0.71) | (0.67) |
Determining Black Diamond's profitability involves analyzing its financial statements and using various financial metrics to determine if Black Diamond is a good buy. For example, gross profit margin measures Black Diamond's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Black Diamond's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Black Diamond's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Black Diamond Therapeutics. Check Black Diamond's Beneish M Score to see the likelihood of Black Diamond's management manipulating its earnings.
Evaluate Black Diamond's management efficiency
Black Diamond Therap has return on total asset (ROA) of (0.4041) % which means that it has lost $0.4041 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8338) %, meaning that it created substantial loss on money invested by shareholders. Black Diamond's management efficiency ratios could be used to measure how well Black Diamond manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.55 in 2024. Return On Capital Employed is likely to drop to -0.65 in 2024. At this time, Black Diamond's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 3 M in 2024, whereas Net Tangible Assets are likely to drop slightly above 100.8 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.66 | 2.79 | |
| Tangible Book Value Per Share | 2.66 | 2.79 | |
| Enterprise Value Over EBITDA | (1.08) | (1.13) | |
| Price Book Value Ratio | 1.06 | 1.11 | |
| Enterprise Value Multiple | (1.08) | (1.13) | |
| Price Fair Value | 1.06 | 1.11 | |
| Enterprise Value | 68.1 M | 64.7 M |
The analysis of Black Diamond's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Black Diamond's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Black Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 2.475 |
Basic technical analysis of Black Stock
As of the 21st of October, Black Diamond shows the risk adjusted performance of (0.1), and Mean Deviation of 4.04. Black Diamond Therap technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Black Diamond's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Black Diamond insiders, such as employees or executives, is commonly permitted as long as it does not rely on Black Diamond's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Black Diamond insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Black Diamond's Outstanding Corporate Bonds
Black Diamond issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Black Diamond Therap uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Black bonds can be classified according to their maturity, which is the date when Black Diamond Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Understand Black Diamond's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Black Diamond's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.1) | |||
| Market Risk Adjusted Performance | (0.28) | |||
| Mean Deviation | 4.04 | |||
| Coefficient Of Variation | (741.54) | |||
| Standard Deviation | 5.24 | |||
| Variance | 27.46 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.94) | |||
| Total Risk Alpha | (1.30) | |||
| Treynor Ratio | (0.29) | |||
| Maximum Drawdown | 26.97 | |||
| Value At Risk | (8.30) | |||
| Potential Upside | 7.07 | |||
| Skewness | 0.4897 | |||
| Kurtosis | 0.7572 |
| Risk Adjusted Performance | (0.1) | |||
| Market Risk Adjusted Performance | (0.28) | |||
| Mean Deviation | 4.04 | |||
| Coefficient Of Variation | (741.54) | |||
| Standard Deviation | 5.24 | |||
| Variance | 27.46 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.94) | |||
| Total Risk Alpha | (1.30) | |||
| Treynor Ratio | (0.29) | |||
| Maximum Drawdown | 26.97 | |||
| Value At Risk | (8.30) | |||
| Potential Upside | 7.07 | |||
| Skewness | 0.4897 | |||
| Kurtosis | 0.7572 |
Consider Black Diamond's intraday indicators
Black Diamond intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Black Diamond stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Black Diamond Corporate Filings
8K | 7th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 20th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 8th of August 2024 An amendment to the original Schedule 13D filing | ViewVerify |
13A | 10th of July 2024 An amended filing to the original Schedule 13G | ViewVerify |
Black Stock media impact
Far too much social signal, news, headlines, and media speculation about Black Diamond that are available to investors today. That information is available publicly through Black media outlets and privately through word of mouth or via Black internal channels. However, regardless of the origin, that massive amount of Black data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Black Diamond news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Black Diamond relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Black Diamond's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Black Diamond alpha.
Black Diamond Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Black Diamond can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Black Diamond Corporate Management
| Melanie Morrison | Sr Operations | Profile | |
| Fang PharmD | Principal CFO | Profile | |
| Christopher Roberts | Advisor | Profile | |
| Elizabeth Montgomery | Chief Officer | Profile | |
| TaiAn Lin | VP Biology | Profile | |
| JD Esq | COO Counsel | Profile | |
| Elizabeth Buck | CoFounder Officer | Profile |
Additional Tools for Black Stock Analysis
When running Black Diamond's price analysis, check to measure Black Diamond's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Black Diamond is operating at the current time. Most of Black Diamond's value examination focuses on studying past and present price action to predict the probability of Black Diamond's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Black Diamond's price. Additionally, you may evaluate how the addition of Black Diamond to your portfolios can decrease your overall portfolio volatility.